Literature DB >> 17345610

What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma.

Hidde M Kroon1, Lori Lowe, Sandra Wong, Doug Fullen, Lyndon Su, Vincent Cimmino, Alfred E Chang, Timothy Johnson, Michael S Sabel.   

Abstract

INTRODUCTION: Many surgeons use the "10% rule" to define whether a lymph node is a sentinel node (SLN) when staging malignant melanoma. However, this increases the number of SLN removed and the time and cost of the procedure. We examined the impact of raising this threshold on the accuracy of the procedure.
METHODS: We reviewed the records of 561 patients with melanoma (624 basins) who underwent SLN with technetium Tc99 labeled sulfur colloid using a definition of a SLN as 10% of that of the node with the highest counts per minute (CPM).
RESULTS: Of the 624 basins, 154 (25%) were positive for metastases. An average of 1.9 nodes per basin were removed (range 1-6). Metastases were found in the hottest node in 137 cases (89% of positive basins, 97% of basins overall). Increasing the threshold above 10% decreased the number of nodes excised and the costs involved, but incrementally raised the number of false negative cases above baseline (a 4% increase for a "20% rule," 5% for a "30% rule," 6% for a "40% rule," and 7% for a "50% rule"). Taking only the hottest node would raise the false negative rate by 11%.
CONCLUSIONS: Although using thresholds higher than 10% for the definition of a SLN will minimize the extent of surgery and decrease the costs associated with the procedure, it will compromise the accuracy of the procedure and is not recommended. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345610     DOI: 10.1002/jso.20729

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?

Authors:  Andrei Rios-Cantu; Ying Lu; Victor Melendez-Elizondo; Michael Chen; Alejandra Gutierrez-Range; Niloofar Fadaki; Suresh Thummala; Carla West-Coffee; James Cleaver; Mohammed Kashani-Sabet; Stanley P L Leong
Journal:  Clin Exp Metastasis       Date:  2017-07-11       Impact factor: 5.150

2.  Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye.

Authors:  Yinin Hu; Patrick D Melmer; Craig L Slingluff
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.

Authors:  Robert Rosenblatt; Markus Johansson; Farhood Alamdari; Alexander Sidiki; Benny Holmström; Johan Hansson; Janos Vasko; Per Marits; Susanne Gabrielsson; Katrine Riklund; Ola Winqvist; Amir Sherif
Journal:  World J Urol       Date:  2016-10-13       Impact factor: 4.226

5.  Contemporary use of sentinel lymph node biopsy in the head and neck.

Authors:  Nolan B Seim; Chadwick L Wright; Amit Agrawal
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-07-25

6.  Evaluation of camera-based freehand SPECT in preoperative sentinel lymph node mapping for melanoma patients.

Authors:  Annie K Kogler; Andrew M Polemi; Surabhi Nair; Stanislaw Majewski; Lynn T Dengel; Craig L Slingluff; Brian Kross; S J Lee; J E McKisson; John McKisson; Andrew G Weisenberger; Benjamin L Welch; Thomas Wendler; Philipp Matthies; Joerg Traub; Michael Witt; Mark B Williams
Journal:  EJNMMI Res       Date:  2020-11-11       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.